Evidence map›Paper›PMID 36968841›Full record

ArticleFrontiers in medicine2023

Case report: Thyroid sarcoidosis as a rare localization of the disease: Report of two cases and review of the literature.

Svetlana Kašiković Lečić, Jovan Javorac, Aleksandra Lovrenski, Jelena Đokić, Danica Sazdanić Velikić, Dejan Živanović

Open access · goldFull text readCase Reports
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Svetlana Kašiković LečićDepartment of Internal Medicine, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Jovan JavoracDepartment of Internal Medicine, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Aleksandra LovrenskiInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia.
Jelena ĐokićInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia.
Danica Sazdanić VelikićInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia.
Dejan ŽivanovićDepartment of Psychology, College of Social Work, Belgrade, Serbia.
Institute for Pulmonary Diseases of Vojvodina · RSUniversity of Novi Sad · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoidosis is a multi-systemic disease of unknown etiology that is characterized by the formation of non-necrotizing and non-caseating granulomas in affected organs. Sarcoidosis granulomas can form in any organ, but the lungs and intrathoracic lymph nodes are the most commonly affected. Thyroid involvement in sarcoidosis is very rare, with prevalence estimates of 1-4.5% in case series of autopsied patients with systemic sarcoidosis. It is extremely rare for sarcoidosis to occur solely in the thyroid gland, but it is usually associated with the involvement of other organs, primarily the lungs and lymph nodes. Typical manifestations are diffuse goiter and solitary or multiple thyroid nodules. Thyroid function remains intact in the majority of cases, but sometimes it can result in hypothyroidism or hyperthyroidism. The diagnosis can be made after fine needle aspiration cytology, but usually it is diagnosed as an incidental finding while analyzing thyroidectomy tissue or during autopsy. Oral steroids are the cornerstone of thyroid sarcoidosis management, along with specific endocrinological treatment on some occasions. Given that we found only 71 reports of thyroid sarcoidosis available in the literature, we created and analyzed a cohort of 24 patients with thyroid sarcoidosis who were described in the literature in the 21st century and reported two additional cases of thyroid sarcoidosis.

Indexed as

diagnosisprevalencesarcoidosisthyroidtreatment

Identifiers

PMID36968841
PMCPMC10036575
OpenAlexW4323859257

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read50
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.